Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
1.850
+0.400 (27.59%)
Jun 12, 2025, 9:34 AM - Market open

Klotho Neurosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020 2017 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Selling, General & Admin
3.62.890.630.570.290.17
Upgrade
Operating Expenses
6.465.540.630.571.110.91
Upgrade
Operating Income
-6.46-5.54-0.63-0.57-1.11-0.91
Upgrade
Interest Expense
-0.91-0.36-0.08-0.02--
Upgrade
Interest & Investment Income
-----0
Upgrade
Other Non Operating Income (Expenses)
-0.35-0.25000-
Upgrade
EBT Excluding Unusual Items
-7.71-6.15-0.71-0.6-1.11-0.91
Upgrade
Pretax Income
-7.71-6.15-0.71-0.6-1.11-0.91
Upgrade
Earnings From Continuing Operations
-7.71-6.15-0.71-0.6-1.11-0.91
Upgrade
Net Income
-7.71-6.15-0.71-0.6-1.11-0.91
Upgrade
Net Income to Common
-7.71-6.15-0.71-0.6-1.11-0.91
Upgrade
Shares Outstanding (Basic)
2219151,045172-
Upgrade
Shares Outstanding (Diluted)
2219151,045172-
Upgrade
Shares Change (YoY)
-97.86%27.21%-98.55%508.33%--
Upgrade
EPS (Basic)
-0.35-0.32-0.05-0.00-0.01-
Upgrade
EPS (Diluted)
-0.35-0.32-0.05-0.00-0.01-
Upgrade
EBIT
-6.46-5.54-0.63-0.57-1.11-0.91
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q